Increase Canadian biotech innovation, research and commercialization. Through a constructive working relationship with policymakers and regulators establish industry data/ analytics to support an ongoing working relationship in support of industry/ government objectives for the sector.
Establish a globally competitive regulatory policy framework to support all aspects of Canadian biotechnology. Increase investment in Canadian biotechnology innovation, research and commercialization with the aim of establishing globally competitive and commercial Canadian-based biotechnology companies.
Establish Canada and Canadian biotechnology innovation as a destination for investment capital.
Upcoming EventsView All
Company HighlightsView All
- Aspect Biosystems Announces US $20 Million Series A Financing to Advance Its Leading Platform for 3D Bioprinting of Human Tissue
- adMare BioInnovations and Accel-Rx Unite to Advance the Canadian Life Sciences Sector
- Tetra Bio-Pharma Receives FDA Orphan Drug Designation for Hepatocellular Carcinoma (December 4, 2019)